William Blair Investment Management LLC bought a new stake in shares of Versigent (NYSE:VGNT – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 261,473 shares of the company’s stock, valued at approximately $11,751,000. William Blair Investment Management LLC owned 0.37% of Versigent at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Fortitude Family Office LLC lifted its position in shares of Versigent by 497.1% during the third quarter. Fortitude Family Office LLC now owns 621 shares of the company’s stock worth $28,000 after acquiring an additional 517 shares in the last quarter. Salomon & Ludwin LLC boosted its holdings in shares of Versigent by 78.3% in the third quarter. Salomon & Ludwin LLC now owns 708 shares of the company’s stock worth $32,000 after acquiring an additional 311 shares during the period. Jacobi Capital Management LLC purchased a new position in shares of Versigent in the third quarter valued at $38,000. Farther Finance Advisors LLC grew its position in shares of Versigent by 53.1% in the third quarter. Farther Finance Advisors LLC now owns 1,052 shares of the company’s stock valued at $47,000 after purchasing an additional 365 shares in the last quarter. Finally, Signaturefd LLC grew its position in shares of Versigent by 40.0% in the third quarter. Signaturefd LLC now owns 1,121 shares of the company’s stock valued at $50,000 after purchasing an additional 320 shares in the last quarter.
Analyst Upgrades and Downgrades
A number of research firms recently issued reports on VGNT. BNP Paribas Exane reiterated an “outperform” rating and set a $54.00 price objective (down from $55.00) on shares of Versigent in a research note on Thursday, November 5th. Oppenheimer set a $50.00 target price on Versigent in a research note on Tuesday, July 21st. Fox Advisors downgraded Versigent from an “overweight” rating to an “equal weight” rating in a research note on Wednesday, August 5th. TD Cowen lifted their target price on Versigent from $58.00 to $59.00 and gave the company a “buy” rating in a report on Thursday, November 5th. Finally, Evercore reaffirmed an “outperform” rating and set a $65.00 target price on shares of Versigent in a report on Monday, August 10th. Eleven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $55.08.
Read Our Latest Research Report on Versigent
Versigent Stock Performance
Versigent stock opened at $42.12 on Monday. Versigent has a 1-year low of $26.34 and a 1-year high of $50.88. The company has a current ratio of 1.43, a quick ratio of 1.11 and a debt-to-equity ratio of 5.69. The firm has a market capitalization of $2.98 billion and a PE ratio of 11.00. The firm’s 50 day simple moving average is $44.26 and its 200 day simple moving average is $42.67.
Versigent (NYSE:VGNT – Get Free Report) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $1.91 EPS for the quarter, beating the consensus estimate of $1.79 by $0.12. Versigent had a net margin of 5.47% and a return on equity of 88.25%. The firm had revenue of $2.45 billion during the quarter, compared to the consensus estimate of $2.42 billion. As a group, analysts expect that Versigent will post 7.37 earnings per share for the current fiscal year.
Versigent Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Stockholders of record on Friday, December 4th will be issued a $0.13 dividend. The ex-dividend date of this dividend is Friday, December 4th. This represents a $0.52 annualized dividend and a dividend yield of 1.2%.
Insider Activity
In related news, Director Kevin Clark sold 47,761 shares of the stock in a transaction on Thursday, October 8th. The stock was sold at an average price of $44.36, for a total value of $2,118,677.96. Following the sale, the director owned 27,571 shares in the company, valued at approximately $1,223,049.56. This trade represents a 63.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders sold a total of 220,000 shares of company stock valued at $10,065,848 in the last quarter.
Versigent Profile
Versigent PLC is involved in the design, manufacturing and delivery of low and high voltage power electrical architectures. Versigent PLC is based in SCHAFFHAUSEN, Switzerland.
Featured Articles
- Five stocks we like better than Versigent
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding VGNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Versigent (NYSE:VGNT – Free Report).
Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.
